Lupin Earns Great Place To Work Certification for 2026-27

Global pharmaceutical leader Lupin has been awarded the prestigious Great Place To Work® Certification™ for the 2026-27 period. This recognition highlights the company’s commitment to building an inclusive, values-driven culture across its global operations. With a workforce of over 24,000 professionals, the company achieved a robust 85% employee participation rate during the evaluation process, underscoring its focus on employee experience and professional development.

Global Recognition for Workplace Excellence

Lupin has officially attained the Great Place To Work® Certification™, a gold standard for measuring workplace excellence. This global milestone covers all of the company’s subsidiaries and geographies, reflecting a unified commitment to creating an environment where employees feel respected, valued, and empowered.

Commitment to Workforce Development

As part of its people-first strategy, Lupin continues to invest heavily in its global workforce. In FY25 alone, the company dedicated INR 40 billion to employee benefits and facilitated over 1.25 million hours of training. These investments are designed to support the professional growth of its 24,000-strong team across 15 manufacturing sites and 7 research centers worldwide.

Empowering an Inclusive Culture

Commenting on the achievement, Yashwant Mahadik, President – Global Human Resources at Lupin, noted that the certification validates the company’s efforts to maintain a values-driven workplace. The company remains focused on further strengthening its organizational culture and continuously enhancing the employee experience to drive innovation in patient health outcomes.

Source: BSE

Previous Article

HUDCO Independent Directors Conclude Tenure

Next Article

Choice International Limited Promoter Pledges Additional Shares for Credit Facility